Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1180661
Reference Type
Journal Article
Title
Classification of antidotes: practical considerations. Part II
Author(s)
Lapostolle, E; Bismuth, C; Baud, F
Year
1999
Is Peer Reviewed?
1
Journal
La Semaine des Hôpitaux
ISSN:
0037-1777
Volume
75
Issue
3-4
Page Numbers
108-114
Web of Science Id
WOS:000078527500009
Abstract
TABLE OF CONTENTS:
1) Introduction
2) Antidotes with toxicokinetic effects
Antidotes that restrict bioavailability of the poison: activated charcoal; others...
Antidotes that enhance elimination of the unchanged poison
By the lungs: oxygen in acute carbon monoxide poisoning; By the kidneys; deferoxamine in acute iron poisoning
Antidotes that activate metabolic pathways responsible for inactivation of the poison
N-acetylcysteine in acute acetaminophen poisoning, methylene blue in toxic methemoglobinemia - Antidotes that inhibit metabolic pathways responsible for activation of the poison: ethanol or 4-methyl-pyrazole in acute methanol or ethylene glycol poisoning
Antidotes that modify distribution of the poison in the body: thiosulfate, dicobalt EDTA, and cobalamine in acute cyanide poisoning
Fab fragment antibodies in acute digitalis poisoning,
3) Antidotes with toxicodynamic effects
Antidotes that displace the poison from its target: flumazenil in acute benzodiazepine poisoning, naloxone in acute opiate poisoning
Antidotes that bypass the poison-receptor link glucagon in acute beta-adrenoceptor antagonist poisoning.
Keywords
poisoning; antidotes
Tags
•
Methanol (Non-Cancer)
Search 2012
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity